| Ident. | Authors (with country if any) | Title |
|---|
| 000184 (2007) |
Y. Imai [Autriche] ; K. Kuba [Autriche] ; J. M. Penninger [Autriche] | Angiotensin-converting enzyme 2 in acute respiratory distress syndrome |
| 000201 (2008) |
Ling-Hon Matthew Chu [République populaire de Chine] ; Siu-Hong Chan [République populaire de Chine] ; Sau-Na Tsai [République populaire de Chine] ; Yi Wang [République populaire de Chine] ; Christopher Hon-Ki Cheng [République populaire de Chine] ; Kam-Bo Wong [République populaire de Chine] ; Mary Miu-Yee Waye [République populaire de Chine] ; Sai-Ming Ngai [République populaire de Chine, Hong Kong] | Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS‐CoV): In search of potent SARS‐CoV entry inhibitors |
| 000302 (2004) |
C. Sylvester-Hvid [Danemark] ; M. Nielsen [Danemark] ; K. Lamberth [Danemark] ; G. R Der [Danemark] ; S. Justesen [Danemark] ; C. Lundegaard [Danemark] ; P. Worning [Danemark] ; H. Thomadsen [Danemark] ; O. Lund [Danemark] ; S. Brunak [Danemark] ; S. Buus [Danemark] | SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation |
| 000405 (2015) |
Antonello Pessi [Italie] | Cholesterol‐conjugated peptide antivirals: a path to a rapid response to emerging viral diseases |
| 000537 (2007) |
Ajoy Basak ; Abhijit Mitra [États-Unis] ; Sarmistha Basak ; Carolyn Pasko ; Michel Chrétien ; Pamela Seaton [États-Unis] | A Fluorogenic Peptide Containing the Processing Site of Human SARS Corona Virus S‐Protein: Kinetic Evaluation and NMR Structure Elucidation |
| 000707 (2006) |
S C S. Chow [République populaire de Chine] ; C Y S. Ho [Hong Kong] ; T T Y. Tam [République populaire de Chine] ; C. Wu [États-Unis] ; T. Cheung [République populaire de Chine] ; P K S. Chan [Hong Kong] ; M H L. Ng [Hong Kong] ; P K Hui [Hong Kong] ; H K Ng [Hong Kong] ; D M Y. Au [République populaire de Chine] ; A W I. Lo [Hong Kong] | Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients |
| 000891 (2006) |
Samer I. Al-Gharabli [Jordanie] ; Syed T. Ali Shah ; Steffen Weik ; Marco F. Schmidt [Allemagne] ; Jeroen R. Mesters [Allemagne] ; Daniel Kuhn [Allemagne] ; Gerhard Klebe [Allemagne] ; Rolf Hilgenfeld [Allemagne] ; Jörg Rademann [Allemagne] | An Efficient Method for the Synthesis of Peptide Aldehyde Libraries Employed in the Discovery of Reversible SARS Coronavirus Main Protease (SARS‐CoV Mpro) Inhibitors |
| 000990 (2004) |
Paul K. S. Chan [République populaire de Chine, Hong Kong] ; W. K. To [République populaire de Chine] ; Esther Y. M. Liu [République populaire de Chine] ; T. K. Ng [République populaire de Chine] ; John S. Tam [République populaire de Chine] ; Joseph J. Y. Sung [République populaire de Chine] ; Jean-Michel Lacroix [Canada] ; Michel Houde [Canada] | Evaluation of a peptide‐based enzyme immunoassay for anti‐SARS coronavirus IgG antibody |
| 000A90 (2016) |
Kenta Teruya [Japon] ; Yasunao Hattori [Japon] ; Yasuhiro Shimamoto [Japon] ; Kazuya Kobayashi [Japon] ; Akira Sanjoh [Japon] ; Atsushi Nakagawa [Japon] ; Eiki Yamashita [Japon] ; Kenichi Akaji [Japon] | Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza‐decaline scaffold |
| 000D96 (2012) |
Nicholas J. Ede [Australie] ; Jeffrey Hill [Singapour] ; Joma K. Joy [Singapour] ; Anne-Marie Ede [Australie] ; Merran L. Koppens [Australie] | Solid‐phase synthesis and screening of a library of C‐terminal arginine peptide aldehydes against Murray Valley encephalitis virus protease |
| 001307 (2007) |
A. P. J Middelberg [Australie] ; L. He [Australie] ; A. F Dexter [Australie] ; H.-H Shen [Royaume-Uni] ; S. A Holt [Royaume-Uni] ; R. K Thomas [Royaume-Uni] | The interfacial structure and Young's modulus of peptide films having switchable mechanical properties |
| 001457 (2004) |
A. Hill [États-Unis] ; C. Li [États-Unis] ; F. Tio [États-Unis] ; M. Imran [États-Unis] | Peptide‐Coated Vascular Grafts: An In Vivo Study in Sheep |
| 001575 (2006) |
Justin Stebbing ; Tom Powles ; Mark Nelson [Royaume-Uni] ; Mark Bower [Royaume-Uni] | Significance of Variation Within HIV, EBV, and KSHV Subtypes |
| 001599 (2008) |
Ning Liu [République populaire de Chine] ; Wenjun Song [République populaire de Chine] ; Pui Wang [République populaire de Chine] ; Kimchung Lee [République populaire de Chine] ; Wan Chan [République populaire de Chine] ; Honglin Chen [République populaire de Chine, Hong Kong] ; Zongwei Cai [République populaire de Chine, Hong Kong] | Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells |
| 001624 (2004) |
F. J. Warner [Royaume-Uni, Australie] ; A. I. Smith [Australie] ; N. M. Hooper [Royaume-Uni] ; A. J. Turner [Royaume-Uni] | What’s new in the renin-angiotensin system? |
| 001768 (2007) |
Pojchong Chotiyarnwong ; Guillaume B. Stewart-Jones ; Michael J. Tarry ; Wanwisa Dejnirattisai ; Christian Siebold ; Michael Koch ; David I. Stuart ; Karl Harlos ; Prida Malasit ; Gavin Screaton ; Juthathip Mongkolsapaya ; E. Yvonne Jones | Humidity control as a strategy for lattice optimization applied to crystals of HLA‐A*1101 complexed with variant peptides from dengue virus |
| 001969 (2009) |
Takanori Kanazawa [Japon] ; Yuuki Takashima [Japon] ; Yasunori Shibata [Japon] ; Miki Tsuchiya [Japon] ; Toshiaki Tamura [Japon] ; Hiroaki Okada [Japon] | Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses |
| 001B98 (2013) |
Jennifer C. Holmes [États-Unis] ; Savannah G. Holmer [États-Unis] ; Peter Ross [États-Unis] ; Adam S. Buntzman [États-Unis] ; Jeffrey A. Frelinger [États-Unis] ; Paul R. Hess [États-Unis] | Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K |
| 001C11 (2009) |
Doreen M. Floss [Allemagne] ; Markus Sack [Allemagne] ; Elsa Arcalis [Autriche] ; Johannes Stadlmann [Autriche] ; Heribert Quendler [Autriche] ; Thomas Rademacher [Allemagne] ; Eva Stoger [Autriche] ; Jürgen Scheller [Allemagne] ; Rainer Fischer [Allemagne] ; Udo Conrad [Allemagne] | Influence of elastin‐like peptide fusions on the quantity and quality of a tobacco‐derived human immunodeficiency virus‐neutralizing antibody |
| 001D23 (2011) |
Wang Wang [Canada] ; Sreedhar Bodiga [Canada] ; Subhash K. Das [Canada] ; Jennifer Lo [Canada] ; Vaibhav Patel [Canada] ; Gavin Y. Oudit [Canada] | Role of ACE2 in diastolic and systolic heart failure |
| 001D54 (2009) |
Sabine Gilch [Allemagne] ; Hermann M. Sch Tzl [Allemagne] | Aptamers against prion proteins and prions |
